AR059327A1 - Monohidrato de rimonabant su procedimiento de preparacion y composiciones farmaceuticas que lo contienen - Google Patents
Monohidrato de rimonabant su procedimiento de preparacion y composiciones farmaceuticas que lo contienenInfo
- Publication number
- AR059327A1 AR059327A1 ARP070100477A ARP070100477A AR059327A1 AR 059327 A1 AR059327 A1 AR 059327A1 AR P070100477 A ARP070100477 A AR P070100477A AR P070100477 A ARP070100477 A AR P070100477A AR 059327 A1 AR059327 A1 AR 059327A1
- Authority
- AR
- Argentina
- Prior art keywords
- rimonabant
- monohidrate
- pharmaceutical compositions
- compositions containing
- preparation procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Reivindicacion 2: La forma cristalina del monohidrato de rimonabant segun la reivindicacion 1, caracterizada por un pico de fusion entre 95°C+- 5°C y 115°C+- 5°C.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0601253A FR2897060B1 (fr) | 2006-02-08 | 2006-02-08 | Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
AR059327A1 true AR059327A1 (es) | 2008-03-26 |
Family
ID=37075667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070100477A AR059327A1 (es) | 2006-02-08 | 2007-02-06 | Monohidrato de rimonabant su procedimiento de preparacion y composiciones farmaceuticas que lo contienen |
Country Status (20)
Country | Link |
---|---|
US (1) | US20090048449A1 (es) |
EP (1) | EP1984341A1 (es) |
JP (1) | JP2009526025A (es) |
KR (1) | KR20080093042A (es) |
CN (1) | CN101405271A (es) |
AR (1) | AR059327A1 (es) |
AU (1) | AU2007213649A1 (es) |
BR (1) | BRPI0707711A2 (es) |
CA (1) | CA2641494A1 (es) |
DO (1) | DOP2007000023A (es) |
EA (1) | EA200870236A1 (es) |
FR (1) | FR2897060B1 (es) |
GT (1) | GT200700014A (es) |
IL (1) | IL192963A0 (es) |
MA (1) | MA30312B1 (es) |
NO (1) | NO20083521L (es) |
TW (1) | TW200804343A (es) |
UY (1) | UY30137A1 (es) |
WO (1) | WO2007090949A1 (es) |
ZA (1) | ZA200806713B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2057144A4 (en) * | 2006-09-01 | 2010-06-02 | Hetero Drugs Ltd | NEW POLYMORPHIC FROM RIMONABANT |
WO2008056377A2 (en) * | 2006-11-06 | 2008-05-15 | Cadila Healthcare Limited | Polymorphic forms of rimonabant |
MX2017007426A (es) * | 2014-12-08 | 2018-04-20 | Crystal Pharmatech Co Ltd | Formas cristalinas de complejo supramolecular trisodico que comprende valsartan y ahu-377 y metodos de las mismas. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2713225B1 (fr) * | 1993-12-02 | 1996-03-01 | Sanofi Sa | N-pipéridino-3-pyrazolecarboxamide substitué. |
FR2831883B1 (fr) * | 2001-11-08 | 2004-07-23 | Sanofi Synthelabo | Forme polymorphe du rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant |
JP4746931B2 (ja) * | 2005-07-22 | 2011-08-10 | 株式会社日立製作所 | フラットディスプレイパネルモジュール及びフラットディスプレイ装置 |
EP2057144A4 (en) * | 2006-09-01 | 2010-06-02 | Hetero Drugs Ltd | NEW POLYMORPHIC FROM RIMONABANT |
WO2008035023A1 (en) * | 2006-09-19 | 2008-03-27 | Cipla Limited | Polymorphs of rimonabant |
-
2006
- 2006-02-08 FR FR0601253A patent/FR2897060B1/fr not_active Expired - Fee Related
-
2007
- 2007-02-01 DO DO2007000023A patent/DOP2007000023A/es unknown
- 2007-02-05 CN CNA200780004742XA patent/CN101405271A/zh active Pending
- 2007-02-05 CA CA002641494A patent/CA2641494A1/fr not_active Abandoned
- 2007-02-05 AU AU2007213649A patent/AU2007213649A1/en not_active Abandoned
- 2007-02-05 WO PCT/FR2007/000201 patent/WO2007090949A1/fr active Application Filing
- 2007-02-05 EP EP07730917A patent/EP1984341A1/fr not_active Withdrawn
- 2007-02-05 EA EA200870236A patent/EA200870236A1/ru unknown
- 2007-02-05 JP JP2008553793A patent/JP2009526025A/ja active Pending
- 2007-02-05 BR BRPI0707711-4A patent/BRPI0707711A2/pt not_active IP Right Cessation
- 2007-02-05 ZA ZA200806713A patent/ZA200806713B/xx unknown
- 2007-02-05 KR KR1020087019391A patent/KR20080093042A/ko not_active Application Discontinuation
- 2007-02-06 AR ARP070100477A patent/AR059327A1/es unknown
- 2007-02-06 GT GT200700014A patent/GT200700014A/es unknown
- 2007-02-08 UY UY30137A patent/UY30137A1/es not_active Application Discontinuation
- 2007-02-08 TW TW096104722A patent/TW200804343A/zh unknown
-
2008
- 2008-07-22 IL IL192963A patent/IL192963A0/en unknown
- 2008-08-06 US US12/186,753 patent/US20090048449A1/en not_active Abandoned
- 2008-08-13 NO NO20083521A patent/NO20083521L/no not_active Application Discontinuation
- 2008-08-26 MA MA31195A patent/MA30312B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
FR2897060B1 (fr) | 2008-07-25 |
EP1984341A1 (fr) | 2008-10-29 |
GT200700014A (es) | 2007-09-19 |
EA200870236A1 (ru) | 2009-02-27 |
NO20083521L (no) | 2008-10-24 |
IL192963A0 (en) | 2009-02-11 |
WO2007090949A1 (fr) | 2007-08-16 |
MA30312B1 (fr) | 2009-04-01 |
ZA200806713B (en) | 2009-10-28 |
UY30137A1 (es) | 2007-09-28 |
DOP2007000023A (es) | 2008-02-15 |
US20090048449A1 (en) | 2009-02-19 |
AU2007213649A1 (en) | 2007-08-16 |
CA2641494A1 (fr) | 2007-08-16 |
JP2009526025A (ja) | 2009-07-16 |
CN101405271A (zh) | 2009-04-08 |
KR20080093042A (ko) | 2008-10-17 |
TW200804343A (en) | 2008-01-16 |
FR2897060A1 (fr) | 2007-08-10 |
BRPI0707711A2 (pt) | 2011-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2008001799A (es) | Composicion farmaceutica que comprende un inhibidor de dipeptidil peptidasa iv. | |
PT1874746E (pt) | Derivados de 1-n-azacicloalquil-3-fenoxipropano úteis para a preparação de medicamentos psicotrópicos | |
EP1879456A4 (en) | PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED RELEASE OF SOLUBILIZING AGENT | |
MX2010005889A (es) | Derivados de tiofeno como agonistas de s1p1/edg1. | |
WO2006096518A3 (en) | Improved gacyclidine formulations | |
SI1948666T1 (sl) | Hiv integrazni inhibitorji | |
HN2006014095A (es) | Forma cristalina ortorrombica del maleato de asenapina | |
IL191907A0 (en) | Azepinoindole derivatives as pharmaceutical agents | |
CU20060038A7 (es) | Forma cristalina gamma-d del clorhidrato de la ivabradina, su procedimiento de preparación y las composiciones farmacéuticas que las contienen | |
NO20090175L (no) | Stabile laquinimod sammensetninger | |
EP1881825A4 (en) | INHIBITORS OF HIV INTEGRASE | |
CU20120002A7 (es) | DERIVADOS DE 1-(5,6-DIHIDROIMIDAZO(1,2-a)PIRAZIN-7(8H)-IL )ETANONA | |
TW200942524A (en) | Novel aminomethyl benzene derivatives | |
EA201101116A1 (ru) | Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина | |
IL185197A0 (en) | Ophthalmological pharmaceutical compositions | |
EA201101118A1 (ru) | Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина | |
EP1910363A4 (en) | INHIBITORS OF HIV INTEGRASE | |
EA201000039A1 (ru) | Фармацевтическая композиция, включающая солифенацин или его фармацевтически приемлемую соль | |
EP1941896A4 (en) | COMPOSITION CONTAINING A DIPEPTIDE FOR ORAL ADMINISTRATION | |
ZA201004031B (en) | Dehydrohalagenation process for the preparation of intermediates useful in providing 6,6-dimethyl-3-azabicyclo-[3.1.0]-hexane compounds | |
MY161749A (en) | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | |
MX2009008249A (es) | Composicion farmaceutica que comprende derivado de camptotecina. | |
HUP0500683A3 (en) | New arylpiprazole salts for producing pharmaceutical composition | |
AR059327A1 (es) | Monohidrato de rimonabant su procedimiento de preparacion y composiciones farmaceuticas que lo contienen | |
AR077915A1 (es) | Forma cristalina de pemirolast |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |